Diagnosis of hepatitis C

Area of Science:

• Hepatology and Virology
• Clinical Diagnostics

Background:

• Hepatitis C virus (HCV) infection poses significant diagnostic and prognostic challenges.
• Accurate assessment is crucial for effective patient management and treatment strategies.
• Established diagnostic markers require evaluation for specific clinical scenarios.

Purpose of the Study:

• To evaluate the clinical utility of various hepatitis C virus (HCV) markers.
• To assess the role of these markers in early diagnosis and prognosis of acute HCV.
• To differentiate acute HCV from flare-ups in carriers and distinguish past from current infections.

Main Methods:

• Detection of HCV-RNA using nested reverse transcription-polymerase chain reaction (RT-PCR).
• Quantitative assay of HCV-RNA via competitive RT-PCR.
• Qualitative and quantitative assays for anti-HCV IgG and IgM antibodies.
• Identification of HCV viral type (genotype and serological group).

Main Results:

• Developed methods include HCV-RNA detection and quantification, antibody assays, and viral typing.
• Evaluated clinical utility for early diagnosis, prognosis, and differentiating infection statuses.
• Assessed marker performance in acute hepatitis C, HCV carrier flare-ups, and resolved infections.

Conclusions:

• HCV-RNA and antibody assays are valuable indicators for hepatitis C diagnosis, condition, and prognosis.
• These markers aid in differentiating acute hepatitis C from other conditions.
• The evaluated methods assist in distinguishing between past and current HCV infections.